News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
728,434 Results
Type
Article (41254)
Company Profile (265)
Press Release (686899)
Multimedia
Podcasts (90)
Webinars (20)
Section
Business (204797)
Career Advice (2037)
Deals (35569)
Drug Delivery (128)
Drug Development (81491)
Employer Resources (173)
FDA (16485)
Job Trends (14973)
News (346729)
Policy (32752)
Tag
2027 BioCapital Elite (1)
2027 Biotech Bay Standard (2)
2027 Genetown Elite (2)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (4)
Academia (2593)
Accelerated approval (45)
Adcomms (25)
Allergies (167)
Alliances (49580)
ALS (200)
Alzheimer's disease (1762)
Antibody-drug conjugate (ADC) (423)
Approvals (16843)
Artificial intelligence (626)
Autoimmune disease (252)
Automation (52)
Bankruptcy (362)
Best Places to Work (11636)
BIOSECURE Act (20)
Biosimilars (215)
Biotechnology (175)
Bladder cancer (184)
Brain cancer (68)
Breast cancer (714)
Cancer (5614)
Cardiovascular disease (454)
Career advice (1724)
Career pathing (41)
CAR-T (314)
CDC (54)
Celiac Disease (2)
Cell therapy (840)
Cervical cancer (45)
Clinical research (70531)
Collaboration (1997)
Company closure (4)
Compensation (1327)
Complete response letters (77)
COVID-19 (2733)
CRISPR (103)
C-suite (1057)
Cystic fibrosis (150)
Data (7486)
Decentralized trials (3)
Denatured (27)
Depression (157)
Dermatology (72)
Diabetes (566)
Diagnostics (6886)
Digital health (53)
Diversity (12)
Diversity, equity & inclusion (45)
Drug discovery (306)
Drug pricing (197)
Drug shortages (31)
Duchenne muscular dystrophy (272)
Earnings (91305)
Editorial (64)
Employer branding (21)
Employer resources (152)
Events (118943)
Executive appointments (1056)
FDA (20076)
Fibrodysplasia Ossificans Progressiva (7)
Friedreich's ataxia (14)
Frontotemporal dementia (34)
Funding (1669)
Gene editing (224)
Generative AI (54)
Gene therapy (680)
GLP-1 (1033)
Government (4716)
Grass and pollen (6)
Guidances (403)
Healthcare (18965)
HIV (76)
Huntington's disease (52)
IgA nephropathy (93)
Immunology and inflammation (278)
Immuno-oncology (86)
Indications (173)
Infectious disease (3065)
Inflammatory bowel disease (204)
Inflation Reduction Act (14)
Influenza (135)
Intellectual property (279)
Interviews (321)
IPO (16656)
IRA (50)
Job creations (3646)
Job search strategy (1434)
JPM (58)
Kidney cancer (18)
Labor market (96)
Layoffs (557)
Leadership (37)
Legal (7952)
Liver cancer (99)
Longevity (31)
Lung cancer (752)
Lymphoma (420)
Machine learning (58)
Management (59)
Manufacturing (983)
MASH (179)
Medical device (13895)
Medtech (13983)
Mergers & acquisitions (20120)
Metabolic disorders (1448)
mRNA (192)
Multiple sclerosis (181)
NASH (17)
Neurodegenerative disease (393)
Neuropsychiatric disorders (101)
Neuroscience (3215)
Neurotech (1)
NextGen: Class of 2026 (6521)
Non-profit (4525)
Now hiring (75)
Obesity (678)
Opinion (283)
Ovarian cancer (206)
Pain (242)
Pancreatic cancer (284)
Parkinson's disease (351)
Partnered (33)
Patents (571)
Patient recruitment (630)
Peanut (61)
People (59421)
Pharmaceutical (59)
Pharmacy benefit managers (32)
Phase 1 (21983)
Phase 2 (31066)
Phase 3 (23123)
Pipeline (7792)
Policy (307)
Postmarket research (2567)
Preclinical (9362)
Press Release (64)
Prostate cancer (284)
Psychedelics (52)
Radiopharmaceuticals (317)
Rare diseases (1024)
Real estate (5965)
Recruiting (70)
Regulatory (25216)
Reports (55)
Research institute (2410)
Resumes & cover letters (354)
Rett syndrome (36)
RNA editing (20)
RSV (88)
Schizophrenia (172)
Series A (277)
Series B (207)
Service/supplier (11)
Sickle cell disease (109)
Special edition (22)
Spinal muscular atrophy (165)
Sponsored (47)
Startups (3630)
State (2)
Stomach cancer (18)
Supply chain (126)
Tariffs (87)
The Weekly (61)
Vaccines (1074)
Venture capital (101)
Weight loss (436)
Women's health (120)
Worklife (20)
Date
Today (174)
Last 7 days (671)
Last 30 days (2795)
Last 365 days (30274)
2026 (10154)
2025 (30171)
2024 (35213)
2023 (40076)
2022 (51174)
2021 (55711)
2020 (54083)
2019 (46540)
2018 (35018)
2017 (32108)
2016 (31482)
2015 (37554)
2014 (31319)
2013 (26348)
2012 (28570)
2011 (29264)
2010 (27328)
Location
Africa (740)
Alabama (91)
Alaska (7)
Arizona (341)
Arkansas (14)
Asia (39584)
Australia (6484)
California (12716)
Canada (3642)
China (1286)
Colorado (545)
Connecticut (549)
Delaware (387)
Europe (85533)
Florida (1907)
Georgia (408)
Hawaii (3)
Idaho (62)
Illinois (1014)
India (88)
Indiana (581)
Iowa (23)
Japan (513)
Kansas (129)
Kentucky (48)
Louisiana (39)
Maine (75)
Maryland (1527)
Massachusetts (9057)
Michigan (353)
Minnesota (692)
Mississippi (6)
Missouri (143)
Montana (33)
Nebraska (29)
Nevada (138)
New Hampshire (84)
New Jersey (3366)
New Mexico (28)
New York (3347)
North Carolina (1610)
North Dakota (8)
Northern California (6336)
Ohio (378)
Oklahoma (23)
Oregon (41)
Pennsylvania (2567)
Puerto Rico (28)
Rhode Island (50)
South America (1112)
South Carolina (85)
South Dakota (2)
Southern California (5003)
Tennessee (205)
Texas (2006)
United States (44950)
Utah (378)
Vermont (1)
Virginia (303)
Washington D.C. (80)
Washington State (1022)
West Virginia (4)
Wisconsin (122)
Wyoming (2)
728,434 Results for "macrogenics inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Regulatory
Patient Death Forces Partial Freeze on MacroGenics’ Gynecologic Cancer Study
A trial of a MacroGenics’ drug temporarily paused enrollment after several safety events, including a fatality. The deceased patient had developed a severe case of neutropenia and concurrent septic shock.
February 25, 2026
·
2 min read
·
Tristan Manalac
Press Releases
FDA Removes Partial Clinical Hold on MacroGenics’ LINNET Study
April 8, 2026
·
5 min read
Press Releases
MacroGenics to Participate in Upcoming March 2026 Investor Conferences
February 27, 2026
·
2 min read
Press Releases
MacroGenics Reports 2025 Financial Results and Highlights Upcoming Planned Data Disclosures
March 9, 2026
·
11 min read
Press Releases
MacroGenics Announces Pausing of Enrollment of New Study Participants in LINNET Trial
February 24, 2026
·
5 min read
Press Releases
MacroGenics to Participate in the Stifel 2025 Healthcare Conference
November 6, 2025
·
1 min read
Press Releases
MacroGenics to Participate in the 8th Annual Evercore Healthcare Conference
November 26, 2025
·
1 min read
Press Releases
MacroGenics Reports Third Quarter 2025 Financial Results and Provides Update on Corporate Progress
November 13, 2025
·
13 min read
Press Releases
MacroGenics Appoints Eric Risser as President and Chief Executive Officer
August 14, 2025
·
5 min read
Press Releases
MacroGenics to Present at H.C. Wainwright 27th Annual Global Investment Conference
September 3, 2025
·
1 min read
1 of 72,844
Next
